US · Healthcare

Orphazyme A/S (OZYMF)

Biotechnology

Orphazyme A/S (OZYMF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for OZYMF

P/E ratio

18.00

Orphazyme A/S (OZYMF) — FAQ

What is OZYMF's P/E ratio?

The price-to-earnings (P/E) ratio for Orphazyme A/S (OZYMF) is 18.00 (data as of 2026-03-24).

Does Orphazyme A/S pay a dividend?

Dividend yield is not available in the current snapshot for Orphazyme A/S (OZYMF). Check the MyAverix Finance app for the latest dividend data.

What sector is Orphazyme A/S in?

Orphazyme A/S (OZYMF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is OZYMF listed on?

OZYMF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)